These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 20439388)
1. Dysregulation of regional endogenous opioid function in borderline personality disorder. Prossin AR; Love TM; Koeppe RA; Zubieta JK; Silk KR Am J Psychiatry; 2010 Aug; 167(8):925-33. PubMed ID: 20439388 [TBL] [Abstract][Full Text] [Related]
2. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Kennedy SE; Koeppe RA; Young EA; Zubieta JK Arch Gen Psychiatry; 2006 Nov; 63(11):1199-208. PubMed ID: 17088500 [TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans. Love TM; Stohler CS; Zubieta JK Arch Gen Psychiatry; 2009 Oct; 66(10):1124-34. PubMed ID: 19805703 [TBL] [Abstract][Full Text] [Related]
4. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Zubieta JK; Ketter TA; Bueller JA; Xu Y; Kilbourn MR; Young EA; Koeppe RA Arch Gen Psychiatry; 2003 Nov; 60(11):1145-53. PubMed ID: 14609890 [TBL] [Abstract][Full Text] [Related]
5. Association of plasma interleukin-18 levels with emotion regulation and μ-opioid neurotransmitter function in major depression and healthy volunteers. Prossin AR; Koch AE; Campbell PL; McInnis MG; Zalcman SS; Zubieta JK Biol Psychiatry; 2011 Apr; 69(8):808-12. PubMed ID: 21145535 [TBL] [Abstract][Full Text] [Related]
6. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans. Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130 [TBL] [Abstract][Full Text] [Related]
7. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Scott DJ; Stohler CS; Egnatuk CM; Wang H; Koeppe RA; Zubieta JK Arch Gen Psychiatry; 2008 Feb; 65(2):220-31. PubMed ID: 18250260 [TBL] [Abstract][Full Text] [Related]
8. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system. Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240 [TBL] [Abstract][Full Text] [Related]
9. Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures. Peciña M; Love T; Stohler CS; Goldman D; Zubieta JK Neuropsychopharmacology; 2015 Mar; 40(4):957-65. PubMed ID: 25308352 [TBL] [Abstract][Full Text] [Related]
10. Borderline personality disorder, impulsivity, and the orbitofrontal cortex. Berlin HA; Rolls ET; Iversen SD Am J Psychiatry; 2005 Dec; 162(12):2360-73. PubMed ID: 16330602 [TBL] [Abstract][Full Text] [Related]
11. Temperament trait Harm Avoidance associates with μ-opioid receptor availability in frontal cortex: a PET study using [(11)C]carfentanil. Tuominen L; Salo J; Hirvonen J; Någren K; Laine P; Melartin T; Isometsä E; Viikari J; Raitakari O; Keltikangas-Järvinen L; Hietala J Neuroimage; 2012 Jul; 61(3):670-6. PubMed ID: 22484309 [TBL] [Abstract][Full Text] [Related]
12. Failure of frontolimbic inhibitory function in the context of negative emotion in borderline personality disorder. Silbersweig D; Clarkin JF; Goldstein M; Kernberg OF; Tuescher O; Levy KN; Brendel G; Pan H; Beutel M; Pavony MT; Epstein J; Lenzenweger MF; Thomas KM; Posner MI; Stern E Am J Psychiatry; 2007 Dec; 164(12):1832-41. PubMed ID: 18056238 [TBL] [Abstract][Full Text] [Related]
13. Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression. Peciña M; Bohnert AS; Sikora M; Avery ET; Langenecker SA; Mickey BJ; Zubieta JK JAMA Psychiatry; 2015 Nov; 72(11):1087-94. PubMed ID: 26421634 [TBL] [Abstract][Full Text] [Related]
14. Whole-brain functional connectivity during script-driven aggression in borderline personality disorder. Ueltzhöffer K; Herpertz SC; Krauch M; Schmahl C; Bertsch K Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():46-54. PubMed ID: 30885789 [TBL] [Abstract][Full Text] [Related]
15. Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans. Prossin AR; Zalcman SS; Heitzeg MM; Koch AE; Campbell PL; Phan KL; Stohler CS; Zubieta JK Neuropsychopharmacology; 2015 Feb; 40(3):554-65. PubMed ID: 25139063 [TBL] [Abstract][Full Text] [Related]
16. Altered central micro-opioid receptor binding after psychological trauma. Liberzon I; Taylor SF; Phan KL; Britton JC; Fig LM; Bueller JA; Koeppe RA; Zubieta JK Biol Psychiatry; 2007 May; 61(9):1030-8. PubMed ID: 16945349 [TBL] [Abstract][Full Text] [Related]
17. Nonacceptance of negative emotions in women with borderline personality disorder: association with neuroactivity of the dorsal striatum. Lamers A; Toepper M; Fernando SC; Schlosser N; Bauer E; Woermann F; Driessen M; Beblo T J Psychiatry Neurosci; 2019 Sep; 44(5):303-312. PubMed ID: 30964611 [TBL] [Abstract][Full Text] [Related]
18. Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms. Nuechterlein EB; Ni L; Domino EF; Zubieta JK Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():69-77. PubMed ID: 27095017 [TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects. Weerts EM; Wand GS; Kuwabara H; Munro CA; Dannals RF; Hilton J; Frost JJ; McCaul ME Alcohol Clin Exp Res; 2011 Dec; 35(12):2162-73. PubMed ID: 21689118 [TBL] [Abstract][Full Text] [Related]
20. It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder. Hsu DT; Sanford BJ; Meyers KK; Love TM; Hazlett KE; Walker SJ; Mickey BJ; Koeppe RA; Langenecker SA; Zubieta JK Mol Psychiatry; 2015 Feb; 20(2):193-200. PubMed ID: 25600108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]